SE9300977D0 - PROCEDURES FOR THE PREPARATION OF INTERMEDIATE PRODUCTS INTENDED FOR PREPARATION OF ANTIHYPERCOL ESTEROLEMIC AGENTS - Google Patents
PROCEDURES FOR THE PREPARATION OF INTERMEDIATE PRODUCTS INTENDED FOR PREPARATION OF ANTIHYPERCOL ESTEROLEMIC AGENTSInfo
- Publication number
- SE9300977D0 SE9300977D0 SE19939300977A SE9300977A SE9300977D0 SE 9300977 D0 SE9300977 D0 SE 9300977D0 SE 19939300977 A SE19939300977 A SE 19939300977A SE 9300977 A SE9300977 A SE 9300977A SE 9300977 D0 SE9300977 D0 SE 9300977D0
- Authority
- SE
- Sweden
- Prior art keywords
- preparation
- agents
- esterolemic
- antihypercol
- procedures
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 239000013067 intermediate product Substances 0.000 title 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 4
- 150000002431 hydrogen Chemical class 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 2
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 239000003529 anticholesteremic agent Substances 0.000 abstract 1
- 125000001246 bromo group Chemical group Br* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 125000002346 iodo group Chemical group I* 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003536 tetrazoles Chemical class 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
This invention provides novel tetrazole intermediates of the formula <IMAGE> wherein R1 and R4 each are independently hydrogen, halogen, C1-4 alkyl, C1-4 alkoxy or trifluoromethyl; R2,R3,R5 and R6 each are independently hydrogen, halogen, C1-4 alkyl or C1-4 alkoxy; B is hydrogen, C1-4 alkoxycarbonyl, CH2Y or CH2Z; Y is hydrogen, hydroxyl or X; Z is <IMAGE> X is bromo, chloro or iodo; R10 is C1-4 alkyl; and R11 is phenyl which is unsubstituted or substituted by one or two C1-4 alkyl or chloro substituents. and processes thereof which are useful for the preparation of antihypercholesterolemic agents.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1855887A | 1987-02-25 | 1987-02-25 | |
| US07/151,512 US4898949A (en) | 1987-02-25 | 1988-02-18 | Intermediates for the preparation of antihypercholesterolemic tetrazole compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| SE9300977L SE9300977L (en) | |
| SE9300977D0 true SE9300977D0 (en) | 1993-03-24 |
| SE512485C2 SE512485C2 (en) | 2000-03-20 |
Family
ID=26691250
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8800637A SE504553C2 (en) | 1987-02-25 | 1988-02-24 | Intermediates and Methods for Preparation of Antihypercholesterolemic Tetrazole Compounds |
| SE9300977A SE512485C2 (en) | 1987-02-25 | 1993-03-24 | Process for the preparation of intermediates intended for the preparation of antihypercholesterolemic agents |
| SE9300976A SE503201C2 (en) | 1987-02-25 | 1993-03-24 | Tetrazole intermediates for use in the preparation of novel inhibitors of the enzyme HMG-CoA reductase |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8800637A SE504553C2 (en) | 1987-02-25 | 1988-02-24 | Intermediates and Methods for Preparation of Antihypercholesterolemic Tetrazole Compounds |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE9300976A SE503201C2 (en) | 1987-02-25 | 1993-03-24 | Tetrazole intermediates for use in the preparation of novel inhibitors of the enzyme HMG-CoA reductase |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US4898949A (en) |
| JP (1) | JP2603284B2 (en) |
| KR (1) | KR960007167B1 (en) |
| CN (1) | CN1030077C (en) |
| AT (1) | AT395588B (en) |
| AU (1) | AU610562B2 (en) |
| BE (1) | BE1002115A3 (en) |
| CA (1) | CA1328269C (en) |
| CH (1) | CH678182A5 (en) |
| DE (1) | DE3805789C2 (en) |
| DK (2) | DK97388A (en) |
| ES (1) | ES2009547A6 (en) |
| FI (1) | FI96600C (en) |
| FR (1) | FR2611201B1 (en) |
| GB (1) | GB2202845B (en) |
| GR (1) | GR1000473B (en) |
| HU (3) | HU201532B (en) |
| IE (1) | IE61608B1 (en) |
| IT (1) | IT1216752B (en) |
| LU (1) | LU87143A1 (en) |
| MY (1) | MY102290A (en) |
| NL (1) | NL8800468A (en) |
| NO (1) | NO178432C (en) |
| NZ (1) | NZ223621A (en) |
| PT (1) | PT86821B (en) |
| SE (3) | SE504553C2 (en) |
| YU (1) | YU46781B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4870187A (en) * | 1988-08-23 | 1989-09-26 | Bristol-Myers Company | Antihypercholesterolemic tetrazol-1-yl compounds |
| FI94339C (en) | 1989-07-21 | 1995-08-25 | Warner Lambert Co | Process for the preparation of pharmaceutically acceptable [R- (R *, R *)] - 2- (4-fluorophenyl) -, - dihydroxy-5- (1-methylethyl) -3-phenyl-4 - [(phenylamino) carbonyl] -1H- for the preparation of pyrrole-1-heptanoic acid and its pharmaceutically acceptable salts |
| US5260325A (en) * | 1991-08-19 | 1993-11-09 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking tertiary amides |
| CA2137049A1 (en) * | 1993-12-15 | 1995-06-16 | John K. Thottathil | Amino acid salts of and methods for preparing antihypercholesterolemic tetrazole compounds |
| JP2001526256A (en) * | 1997-12-19 | 2001-12-18 | ワーナー−ランバート・エクスポート・リミテッド | Method for synthesizing 1,3-diol |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4160100A (en) * | 1973-03-23 | 1979-07-03 | American Home Products Corporation | Oxamic acid derivatives |
| US4013647A (en) * | 1976-03-23 | 1977-03-22 | American Home Products Corporation | Morpholine containing tetrazole-5-carboxamide derivatives |
| JPS53147073A (en) * | 1977-05-24 | 1978-12-21 | Sankyo Co Ltd | Mevalonolactone derivatives |
| IL60751A (en) * | 1979-08-17 | 1985-04-30 | Merck & Co Inc | 6-(2'-((substituted phenyl)ethyl and-ethenyl)-4-hydroxy-tetrahydro-2h-pyran-2-one derivatives,their preparation and pharmaceutical compositions containing them |
| US4567289A (en) * | 1979-08-17 | 1986-01-28 | Merck & Co., Inc. | Substituted pyranone inhibitors of cholesterol synthesis |
| US4375475A (en) * | 1979-08-17 | 1983-03-01 | Merck & Co., Inc. | Substituted pyranone inhibitors of cholesterol synthesis |
| EP0068038B1 (en) * | 1981-06-29 | 1985-09-25 | Merck & Co. Inc. | (+)-(4r,6s)-(e)-6-(2-(4'-fluoro-3,3',5-trimethyl-(1,1'-biphenyl)-2-yl)ethenyl)-3,4,5,6-tetrahydro-4-hydroxy-2h-pyran-2-one, a process for preparing and a pharmaceutical composition containing the same |
| US4739073A (en) * | 1983-11-04 | 1988-04-19 | Sandoz Pharmaceuticals Corp. | Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof |
| WO1984002131A1 (en) * | 1982-11-22 | 1984-06-07 | Sandoz Ag | Analogs of mevalolactone and derivatives thereof, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals |
| EP0117228B1 (en) * | 1983-01-24 | 1986-11-05 | Sandoz Ag | Analogs of mevalonolactone and derivatives thereof, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals |
| US5105017A (en) * | 1983-07-18 | 1992-04-14 | Eli Lilly And Company | Leukotriene antagonist intermediates |
| CA1327360C (en) * | 1983-11-14 | 1994-03-01 | William F. Hoffman | Oxo-analogs of mevinolin-like antihypercholesterolemic agents |
| KR890001651B1 (en) * | 1984-06-22 | 1989-05-12 | 산도즈 파마슈티칼스 코포레이션 | Process preparing of pyrazoleanalogs and its derivatives of mevalonolactone |
| US4613610A (en) * | 1984-06-22 | 1986-09-23 | Sandoz Pharmaceuticals Corp. | Cholesterol biosynthesis inhibiting pyrazole analogs of mevalonolactone and its derivatives |
| US4668794A (en) * | 1985-05-22 | 1987-05-26 | Sandoz Pharm. Corp. | Intermediate imidazole acrolein analogs |
| US4621099A (en) * | 1985-09-23 | 1986-11-04 | Usv Pharmaceutical Corporation | Polyene compounds useful in the treatment of allergic responses |
| US4681893A (en) * | 1986-05-30 | 1987-07-21 | Warner-Lambert Company | Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis |
| US4678806A (en) * | 1986-09-02 | 1987-07-07 | Merck & Co., Inc. | Prodrugs of antihypercholesterolemic compounds |
| AU601264B2 (en) * | 1987-02-25 | 1990-09-06 | Bristol-Myers Squibb Company | Antihypercholesterolemic tetrazole compounds |
-
1988
- 1988-02-18 US US07/151,512 patent/US4898949A/en not_active Expired - Lifetime
- 1988-02-24 DK DK097388A patent/DK97388A/en not_active Application Discontinuation
- 1988-02-24 SE SE8800637A patent/SE504553C2/en not_active IP Right Cessation
- 1988-02-24 MY MYPI88000180A patent/MY102290A/en unknown
- 1988-02-24 IT IT8819526A patent/IT1216752B/en active
- 1988-02-24 HU HU88885A patent/HU201532B/en not_active IP Right Cessation
- 1988-02-24 HU HU895124A patent/HU201533B/en not_active IP Right Cessation
- 1988-02-24 CH CH691/88A patent/CH678182A5/de not_active IP Right Cessation
- 1988-02-24 IE IE50288A patent/IE61608B1/en not_active IP Right Cessation
- 1988-02-24 GB GB8804281A patent/GB2202845B/en not_active Expired - Fee Related
- 1988-02-24 NZ NZ223621A patent/NZ223621A/en unknown
- 1988-02-24 AU AU12132/88A patent/AU610562B2/en not_active Ceased
- 1988-02-24 DE DE3805789A patent/DE3805789C2/en not_active Expired - Fee Related
- 1988-02-24 AT AT0046088A patent/AT395588B/en not_active IP Right Cessation
- 1988-02-24 KR KR1019880001915A patent/KR960007167B1/en not_active IP Right Cessation
- 1988-02-24 GR GR880100100A patent/GR1000473B/en not_active IP Right Cessation
- 1988-02-24 JP JP63041828A patent/JP2603284B2/en not_active Expired - Fee Related
- 1988-02-24 NO NO880802A patent/NO178432C/en not_active IP Right Cessation
- 1988-02-24 FR FR888802212A patent/FR2611201B1/en not_active Expired - Fee Related
- 1988-02-24 HU HU895133A patent/HU201534B/en not_active IP Right Cessation
- 1988-02-24 FI FI880868A patent/FI96600C/en not_active IP Right Cessation
- 1988-02-24 NL NL8800468A patent/NL8800468A/en not_active Application Discontinuation
- 1988-02-24 CA CA000559671A patent/CA1328269C/en not_active Expired - Fee Related
- 1988-02-24 ES ES8800533A patent/ES2009547A6/en not_active Expired
- 1988-02-24 PT PT86821A patent/PT86821B/en not_active IP Right Cessation
- 1988-02-25 LU LU87143A patent/LU87143A1/en unknown
- 1988-02-25 BE BE8800219A patent/BE1002115A3/en not_active IP Right Cessation
- 1988-02-25 YU YU36488A patent/YU46781B/en unknown
-
1992
- 1992-10-20 CN CN92111551A patent/CN1030077C/en not_active Expired - Fee Related
-
1993
- 1993-03-24 SE SE9300977A patent/SE512485C2/en not_active IP Right Cessation
- 1993-03-24 SE SE9300976A patent/SE503201C2/en not_active IP Right Cessation
-
1997
- 1997-10-06 DK DK113897A patent/DK113897A/en not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE195938T1 (en) | 2-(1',2',4'-TRIAZOLE-3'YLOXYMETHYLENE)-ANILIDES AND THEREOF USE AS PESTOPTIC AGENTS | |
| MX9300821A (en) | HYPOLIPIDEMIC COMPOUNDS. | |
| HUP0203288A2 (en) | Pyrrole derivatives as phosphodiesterase vii inhibitors, pharmaceutical compositions containing them and their use | |
| DE69231445D1 (en) | TRIAZOLE-CONTAINING ANTIFUNGICIDES | |
| DE69131325D1 (en) | INTERMEDIATE CONNECTIONS FOR THE PRODUCTION OF THIOALKYLTHIO CEPHALOSPORINE DERIVATIVES | |
| DK0754682T3 (en) | Aminostilbazole derivative and drug | |
| ATE163921T1 (en) | AZOXYCYANBENZENE DERIVATIVES | |
| FI954016A0 (en) | New compounds | |
| ATE14880T1 (en) | CEPHALOSPORIN COMPOUNDS AND THEIR PRODUCTION. | |
| SE9300977D0 (en) | PROCEDURES FOR THE PREPARATION OF INTERMEDIATE PRODUCTS INTENDED FOR PREPARATION OF ANTIHYPERCOL ESTEROLEMIC AGENTS | |
| NZ221699A (en) | Pyridazinone derivatives; pharmaceutical compositions and intermediates | |
| ATE46159T1 (en) | PYRIDAZINONE, INOTROPIC AGENT. | |
| SE8001556L (en) | TETRAHYDROBENSOTIAZOLYLIMIDAZOLIDINONER | |
| FI933755A (en) | FRAMING PROOF FOR TRANS-PIPERIDINE-2,5-DICARBOXYLATER | |
| DK0449515T3 (en) | New Cephalosporin Intermediates and Processes for Preparation of Intermediates and End Products thereof | |
| ATE39682T1 (en) | DERIVATIVES OF 3-PHENYL-2-PROPENAMINE, THEIR MANUFACTURE AND PHARMACEUTICALS CONTAINING THEM. | |
| EP0028936A3 (en) | 4-carbamoylimidazol-5-ol derivatives, their production and pharmaceutical compositions containing them | |
| MY130817A (en) | Herbicides | |
| ES8502699A1 (en) | Substituted tetrahydrothiopyran-3,5-dione-4-carboxamide. | |
| ATE284379T1 (en) | AMINE DERIVATIVES | |
| DE3873046D1 (en) | N-PHENYLTETRAHYDROPHTHALIMIDES. | |
| DK0532725T3 (en) | Isoxazole derivatives as light filter preparations | |
| YU13197A (en) | Novel 2,3-benzodiazepinic derivatives, production procedure thereof and pharmaceutical preparations containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |